Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Nischarin | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | nischarin | Get druggable targets OG5_133208 | All targets in OG5_133208 |
Onchocerca volvulus | Nischarin homolog | Get druggable targets OG5_133208 | All targets in OG5_133208 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_133208 | All targets in OG5_133208 |
Brugia malayi | hypothetical protein | Get druggable targets OG5_133208 | All targets in OG5_133208 |
Echinococcus granulosus | nischarin | Get druggable targets OG5_133208 | All targets in OG5_133208 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | peptidase, M28 family protein | 0.0318 | 0.3394 | 0.5 |
Onchocerca volvulus | Fxna peptidase homolog | 0.0318 | 0.3394 | 0.3394 |
Echinococcus granulosus | glutaminyl peptide cyclotransferase | 0.0614 | 1 | 1 |
Echinococcus multilocularis | endoplasmic reticulum metallopeptidase 1 | 0.0318 | 0.3394 | 0.3334 |
Loa Loa (eye worm) | hypothetical protein | 0.0318 | 0.3394 | 0.3391 |
Brugia malayi | leucyl aminopeptidase | 0.0318 | 0.3394 | 0.3391 |
Mycobacterium tuberculosis | Conserved protein | 0.0318 | 0.3394 | 0.5 |
Trypanosoma brucei | glutaminyl cyclase, putative | 0.0318 | 0.3394 | 0.5 |
Toxoplasma gondii | hypothetical protein | 0.0318 | 0.3394 | 0.5 |
Echinococcus multilocularis | endoplasmic reticulum metallopeptidase 1 | 0.0318 | 0.3394 | 0.3334 |
Trypanosoma cruzi | glutaminyl cyclase, putative | 0.0318 | 0.3394 | 0.5 |
Brugia malayi | nicalin | 0.0318 | 0.3394 | 0.3391 |
Loa Loa (eye worm) | leucyl aminopeptidase | 0.0318 | 0.3394 | 0.3391 |
Trichomonas vaginalis | Clan MH, family M28, aminopeptidase S-like metallopeptidase | 0.0318 | 0.3394 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0318 | 0.3394 | 0.3391 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0318 | 0.3394 | 0.5 |
Echinococcus multilocularis | glutaminyl peptide cyclotransferase | 0.0614 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0318 | 0.3394 | 0.5 |
Echinococcus granulosus | endoplasmic reticulum metallopeptidase 1 | 0.0318 | 0.3394 | 0.3334 |
Onchocerca volvulus | 0.0318 | 0.3394 | 0.3394 | |
Mycobacterium tuberculosis | Probable lipoprotein aminopeptidase LpqL | 0.0318 | 0.3394 | 0.5 |
Echinococcus multilocularis | n acetylated alpha linked acidic dipeptidase 2 | 0.0318 | 0.3394 | 0.3334 |
Brugia malayi | FXNA | 0.0318 | 0.3394 | 0.3391 |
Loa Loa (eye worm) | hypothetical protein | 0.0318 | 0.3394 | 0.3391 |
Loa Loa (eye worm) | hypothetical protein | 0.0614 | 1 | 1 |
Leishmania major | glutaminyl cyclase, putative | 0.0318 | 0.3394 | 0.5 |
Onchocerca volvulus | Glutaminyl cyclase homolog | 0.0614 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0318 | 0.3394 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0318 | 0.3394 | 0.3391 |
Echinococcus granulosus | endoplasmic reticulum metallopeptidase 1 | 0.0318 | 0.3394 | 0.3334 |
Mycobacterium ulcerans | hypothetical protein | 0.0318 | 0.3394 | 0.5 |
Mycobacterium ulcerans | lipoprotein aminopeptidase LpqL | 0.0318 | 0.3394 | 0.5 |
Schistosoma mansoni | glutaminyl cyclase (M28 family) | 0.0614 | 1 | 1 |
Onchocerca volvulus | Fxna peptidase homolog | 0.0318 | 0.3394 | 0.3394 |
Leishmania major | hypothetical protein, conserved | 0.0318 | 0.3394 | 0.5 |
Onchocerca volvulus | Fxna peptidase homolog | 0.0318 | 0.3394 | 0.3394 |
Trypanosoma cruzi | glutaminyl cyclase, putative | 0.0318 | 0.3394 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 7781 nM | Inhibition of Sprague-Dawley rat imidazoline I1 receptor | ChEMBL. | 21159515 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.